Active Biotech AB (ACTI) - Cash Flow Conversion Efficiency

Latest as of September 2025: -1.600x

Based on the latest financial reports, Active Biotech AB (ACTI) has a cash flow conversion efficiency ratio of -1.600x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-7.20 Million ≈ $-774.83K USD) by net assets (Skr4.50 Million ≈ $484.27K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See ACTI days of operational coverage to measure how many days the company can operate on defensive assets alone.

Active Biotech AB - Cash Flow Conversion Efficiency Trend (2002–2024)

This chart illustrates how Active Biotech AB's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Active Biotech AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Active Biotech AB ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
MLRN Projects and Trade Ltd
TA:MLRN
-0.419x
Lemonsoft Oyj
HE:LEMON
0.093x
Exagen Inc
NASDAQ:XGN
-0.722x
EcoFirst Consolidated Bhd
KLSE:3557
0.008x
LITHIUM IONIC CORP.
F:H3N
N/A
Synchronoss Technologies Inc
NASDAQ:SNCR
0.711x
M.I.TECH Co.Ltd
KQ:179290
0.047x
Ubiquoss Holdings Inc
KQ:078070
0.055x

Annual Cash Flow Conversion Efficiency for Active Biotech AB (2002–2024)

The table below shows the annual cash flow conversion efficiency of Active Biotech AB from 2002 to 2024. For the full company profile with market capitalisation and key ratios, see ACTI market cap.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 Skr32.07 Million
≈ $3.45 Million
Skr-40.40 Million
≈ $-4.35 Million
-1.260x +15.54%
2023-12-31 Skr30.67 Million
≈ $3.30 Million
Skr-45.74 Million
≈ $-4.92 Million
-1.492x +6.15%
2022-12-31 Skr34.51 Million
≈ $3.71 Million
Skr-54.85 Million
≈ $-5.90 Million
-1.589x -60.68%
2021-12-31 Skr46.67 Million
≈ $5.02 Million
Skr-46.17 Million
≈ $-4.97 Million
-0.989x +32.11%
2020-12-31 Skr22.11 Million
≈ $2.38 Million
Skr-32.22 Million
≈ $-3.47 Million
-1.457x -118.79%
2019-12-31 Skr53.78 Million
≈ $5.79 Million
Skr-35.81 Million
≈ $-3.85 Million
-0.666x -44.02%
2018-12-31 Skr87.92 Million
≈ $9.46 Million
Skr-40.65 Million
≈ $-4.37 Million
-0.462x +22.68%
2017-12-31 Skr77.68 Million
≈ $8.36 Million
Skr-46.45 Million
≈ $-5.00 Million
-0.598x -49.20%
2016-12-31 Skr182.56 Million
≈ $19.65 Million
Skr-73.16 Million
≈ $-7.87 Million
-0.401x +66.78%
2015-12-31 Skr180.60 Million
≈ $19.44 Million
Skr-217.89 Million
≈ $-23.45 Million
-1.206x -83.08%
2014-12-31 Skr405.31 Million
≈ $43.62 Million
Skr-267.09 Million
≈ $-28.74 Million
-0.659x -161.28%
2013-12-31 Skr405.41 Million
≈ $43.63 Million
Skr-102.25 Million
≈ $-11.00 Million
-0.252x +64.34%
2012-12-31 Skr339.92 Million
≈ $36.58 Million
Skr-240.40 Million
≈ $-25.87 Million
-0.707x -655.82%
2011-12-31 Skr501.99 Million
≈ $54.02 Million
Skr-46.97 Million
≈ $-5.05 Million
-0.094x +91.34%
2010-12-31 Skr181.76 Million
≈ $19.56 Million
Skr-196.32 Million
≈ $-21.13 Million
-1.080x +9.35%
2009-12-31 Skr188.64 Million
≈ $20.30 Million
Skr-224.77 Million
≈ $-24.19 Million
-1.192x -22.25%
2008-12-31 Skr163.61 Million
≈ $17.61 Million
Skr-159.46 Million
≈ $-17.16 Million
-0.975x +1.04%
2007-12-31 Skr189.57 Million
≈ $20.40 Million
Skr-186.70 Million
≈ $-20.09 Million
-0.985x +40.63%
2006-12-31 Skr60.36 Million
≈ $6.50 Million
Skr-100.13 Million
≈ $-10.78 Million
-1.659x -52.37%
2005-12-31 Skr176.81 Million
≈ $19.03 Million
Skr-192.51 Million
≈ $-20.72 Million
-1.089x -18.08%
2004-12-31 Skr162.30 Million
≈ $17.47 Million
Skr-149.65 Million
≈ $-16.10 Million
-0.922x +7.56%
2003-12-31 Skr289.58 Million
≈ $31.16 Million
Skr-288.83 Million
≈ $-31.08 Million
-0.997x -30.02%
2002-12-31 Skr380.27 Million
≈ $40.92 Million
Skr-291.71 Million
≈ $-31.39 Million
-0.767x --

About Active Biotech AB

ST:ACTI Sweden Biotechnology
Market Cap
$1.73 Billion
Skr16.07 Billion SEK
Market Cap Rank
#19136 Global
#330 in Sweden
Share Price
Skr6.10
Change (1 day)
+3.66%
52-Week Range
Skr0.04 - Skr7.20
All Time High
Skr28.53
About

Active Biotech AB (publ), a biotechnology company, engages in the research, development, and production of pharmaceutical products in Sweden. It is developing Tasquinimod, a small molecule immunomodulator, which is in Phase Ib/IIa clinical trial to treat relapsed refractory multiple myeloma; Laquinimod, a mechanism which is in phase 1 for the treatment of severe inflammatory eye diseases, such as… Read more